Highlights Themis Medicare Limited NSE India S.E.

Equities

THEMISMED

INE083B01024

Market Closed - NSE India S.E. Other stock markets 07:40:31 2024-07-05 am EDT			5-day change	1st Jan Change
212.7 ^INR	+3.41%		+1.44%	-0.46%

May. 14	Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or after July 22, 2024	CI
May. 14	Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or after July 22, 2024	May. 14	CI
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 14	CI
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 14	CI
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 10	CI
Themis Medicare Limited Launches REMITHEM	Nov. 10	CI
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 04	CI
Split: 10 of 1	23-10-09	FA
Split: 10 of 1	23-10-09	FA
Themis Medicare Limited Announces Incorporation of Wholly Owned Subsidiary	23-09-20	CI
Ex-dividend day for final dividend	23-08-31	FA
Themis Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-13	CI
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-13	CI
Themis Medicare Limited Recommends Dividend for Financial Year Ended 31 March 2023	23-05-13	CI
Themis Medicare Gets Drug Controller General of India’s No-Objection for Diclofenac Injection	23-02-17	MT
Themis Medicare Announces DCGI Approval of Remifentanil Hydrochloride 1mg/2mg for Injection for Import and Marketing	23-02-17	CI
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-03	CI
Themis Medicare Launches Drug for Treatment of Menopausal Symptoms in India	23-01-03	MT
Themis Medicare Ltd. Launches Lenzetto Â¡Global Brand of Estradiol Novel Drug Delivery System	23-01-03	CI
Themis Medicare Posts Decline in Fiscal Q2 Consolidated Profit	22-11-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Themis Medicare Limited NSE India S.E.

Equities

THEMISMED

INE083B01024

Highlights

Filters